Silicones may lead to cell death

 

Nijmegen, Netherlands (June 12, 2020) — Silicone molecules from breast implants can initiate processes in human cells that lead to cell death. Researchers from Radboud University have demonstrated this in a new study that will be published on 12 June in Scientific Reports. „However, there are still many questions about what this could mean for the health effects of silicone breast implants. More research is therefore urgently needed,“ says Ger Pruijn, professor of Biomolecular Chemistry at Radboud University.

The possible side effects of silicone breast implants have been debated for decades. There are known cases where the implants have led to severe fatigue, fever, muscle and joint aches, and concentration disturbance. However, there is as yet no scientific study demonstrating the effect silicone molecules can have on human cells that could explain these side effects.

 

Silicone in the body

It is a known fact that breast implants ‚bleed‘, i.e. silicone molecules from the implant pass through the shell and enter the body. Earlier research, in 2016, by Dr Rita Kappel, plastic surgeon, and Radboud university medical center, found that silicone molecules can then migrate through the body via the bloodstream or lymphatic system. The biochemists at Radboud University next asked themselves the follow-up question: what effect might silicone molecules have on cells exposed to it?

 

Cultured cells

Experiments with cultured cells showed that silicones appeared to initiate molecular processes that lead to cell death. „We observed similarities with molecular processes related to programmed cell death, a natural process called apoptosis that has an important function in clearing cells in our body. This effect appeared to depend on the dose of silicone and the size of the silicone molecules. The smaller the molecule, the stronger the effect,“ according to Pruijn.

To investigate the effect of silicones on human cells, the researchers have added small silicone molecules – which also occur in silicone breast implants – to three different types of cultured human cells. „One cell was more sensitive to the effect of silicones than the other two cell types. This suggests that the sensitivity of human cells to silicones varies.“

 

Open questions

The effects the researchers have found lead to many new questions. „We observed that silicones induce molecular changes in cells, but we don’t know yet whether these changes could, for example, lead to an autoimmune response, which could in part explain the negative side effects of implants,“ says Pruijn.

„Caution is advised with drawing conclusions based on these findings because we used cultured cells in our research, not specific human cells such as brain cells or muscle cells. Further research is required to get more clarity.“

 

 

Image: Silicone molecules from breast implants can initiate processes in human cells that lead to cell death. Researchers from Radboud University have demonstrated this in a new study that will be published on 12 June in Scientific Reports. ‚However, there are still many questions about what this could mean for the health effects of silicone breast implants. More research is therefore urgently needed,‘ says Ger Pruijn, professor of Biomolecular Chemistry at Radboud University. Credit: Radboud University

 


Radboud University Nijmegen, 12.06.2020 (tB).

Schlagwörter:

MEDICAL NEWS

New guidance to prevent the tragedy of unrecognized esophageal intubation
Overly restrictive salt intake may worsen outcomes for common form…
COVID-19 vaccines are estimated to have prevanented 20 million deaths…
Novel sleep education learning modules developed for nurse practitioners
Scientists discover how salt in tumours could help diagnose and…

SCHMERZ PAINCARE

Aktuelle Versorgungssituation der Opioidtherapie im Fokus
Individuelle Schmerztherapie mit Opioiden: Patienten im Mittelpunkt
Versorgung verbessern: Deutsche Gesellschaft für Schmerzmedizin fordert die Einführung des…
Pflegeexpertise im Fokus: Schmerzmanagement nach Operationen
Versorgung verbessern: Bundesweite Initiative der Deutschen Gesellschaft für Schmerzmedizin zu…

DIABETES

Menschen mit Diabetes während der Corona-Pandemie unterversorgt? Studie zeigt auffällige…
Suliqua® zur Therapieoptimierung bei unzureichender BOT
„Wissen was bei Diabetes zählt: Gesünder unter 7 PLUS“ gibt…
Kaltplasma bei diabetischem Fußsyndrom wirkt via Wachstumsfaktoren
Typ-1-Diabetes: InRange – auf die Zeit im Zielbereich kommt es…

ERNÄHRUNG

Gesunde Ernährung: „Nicht das Salz und nicht das Fett verteufeln“
Mangelernährung gefährdet den Behandlungserfolg — DGEM: Ernährungsscreening sollte zur klinischen…
Wie eine Diät die Darmflora beeinflusst: Krankenhauskeim spielt wichtige Rolle…
DGEM plädiert für Screening und frühzeitige Aufbautherapie: Stationäre COVID-19-Patienten oft…
Führt eine vegane Ernährungsweise zu einer geringeren Knochengesundheit?

ONKOLOGIE

Nahrungsergänzungsmittel während der Krebstherapie: Es braucht mehr Bewusstsein für mögliche…
Fusobakterien und Krebs
Fortgeschrittenes Zervixkarzinom: Pembrolizumab verlängert Leben
Krebspatienten unter Immuntherapie: Kein Hinweis auf erhöhtes Risiko für schwere…
Aktuelle Kongressdaten zum metastasierten Mammakarzinom und kolorektalen Karzinom sowie Neues…

MULTIPLE SKLEROSE

Multiple Sklerose: Analysen aus Münster erhärten Verdacht gegen das Epstein-Barr-Virus
Aktuelle Daten zu Novartis Ofatumumab und Siponimod bestätigen Vorteil des…
Multiple Sklerose durch das Epstein-Barr-Virus – kommt die MS-Impfung?
Neuer Therapieansatz für Multiple Sklerose und Alzheimer
„Ich messe meine Multiple Sklerose selbst!“ – Digitales Selbstmonitoring der…

PARKINSON

Alexa, bekomme ich Parkinson?
Meilenstein in der Parkinson-Frühdiagnose
Parkinson-Erkrankte besonders stark von Covid-19 betroffen
Gangstörungen durch Kleinhirnschädigung beim atypischen Parkinson-Syndrom
Parkinson-Agenda 2030: Die kommenden 10 Jahre sind für die therapeutische…